{
  "trial_id": "NCT00669864",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes, baseline HbA1c, BMI (Body Mass Index), prior insulin regimen, concomitant oral anti-diabetic drugs (OADs) usage, fasting plasma glucose, postprandial glucose, blood pressure, lipid profile (total cholesterol, LDL, HDL, triglycerides), renal function (serum creatinine, eGFR), liver function tests (ALT, AST).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "BMI",
          "BMI (Body Mass Index)"
        ],
        [
          "HbA1c",
          "baseline HbA1c"
        ],
        [
          "Previous treatment",
          "prior insulin regimen"
        ],
        [
          "Duration of diabetes",
          "duration of diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Race (NIH/OMB)",
        "Weight"
      ],
      "remaining_candidate_features": [
        "concomitant oral anti-diabetic drugs (OADs) usage",
        "fasting plasma glucose",
        "postprandial glucose",
        "blood pressure",
        "lipid profile (total cholesterol, LDL, HDL, triglycerides)",
        "renal function (serum creatinine, eGFR)",
        "liver function tests (ALT, AST)"
      ]
    },
    "processed-gen-response": "Age, gender, duration of diabetes, baseline HbA1c, BMI (Body Mass Index), prior insulin regimen, concomitant oral anti-diabetic drugs (OADs) usage, fasting plasma glucose, postprandial glucose, blood pressure, lipid profile (total cholesterol, LDL, HDL, triglycerides), renal function (serum creatinine, eGFR), liver function tests (ALT, AST)."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Previous Insulin Regimen, Concomitant Oral Anti-diabetic Drugs (OADs),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "HbA1c",
          "Baseline HbA1c"
        ],
        [
          "Duration of diabetes",
          "Duration of Diabetes"
        ],
        [
          "Previous treatment",
          "Previous Insulin Regimen"
        ]
      ],
      "remaining_reference_features": [
        "Weight"
      ],
      "remaining_candidate_features": [
        "Concomitant Oral Anti-diabetic Drugs (OADs)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Previous Insulin Regimen, Concomitant Oral Anti-diabetic Drugs (OADs)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Gender, Ethnicity (Customized), Region of Enrollment, Diabetes duration, BMI, HbA1c, Basal insulin dose, Type of basal insulin, Use of oral anti-diabetic drugs,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "HbA1c",
          "HbA1c"
        ],
        [
          "Previous treatment",
          "Use of oral anti-diabetic drugs"
        ],
        [
          "Duration of diabetes",
          "Diabetes duration"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Race (NIH/OMB)",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Gender",
        "Region of Enrollment",
        "Basal insulin dose",
        "Type of basal insulin"
      ]
    },
    "processed-gen-response": "Age, Gender, Region of Enrollment, Diabetes duration, BMI, HbA1c, Basal insulin dose, Type of basal insulin, Use of oral anti-diabetic drugs"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, BMI, duration of diabetes, HbA1c at screening, type and dose of basal insulin, use of oral anti-diabetic drugs, systolic blood pressure, diastolic blood pressure, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "Duration of diabetes",
          "duration of diabetes"
        ],
        [
          "HbA1c",
          "HbA1c at screening"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Previous treatment",
        "Weight"
      ],
      "remaining_candidate_features": [
        "type and dose of basal insulin",
        "use of oral anti-diabetic drugs",
        "systolic blood pressure",
        "diastolic blood pressure",
        "total cholesterol",
        "LDL cholesterol",
        "HDL cholesterol",
        "triglycerides"
      ]
    },
    "processed-gen-response": "Age, sex, race, BMI, duration of diabetes, HbA1c at screening, type and dose of basal insulin, use of oral anti-diabetic drugs, systolic blood pressure, diastolic blood pressure, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides."
  }
}